Pnc Financial Services Group, Inc. Precision Biosciences Inc Transaction History

Pnc Financial Services Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.96 - $7.76 $1,184 - $3,104	-400 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.07 - $12.52 $3,405 - $5,283	-422 Reduced 51.34%	400 $5,000
Q1 2021 May 07, 2021	SELL	$8.57 - $15.79 $188 - $347	-22 Reduced 2.61%	822 $8,000
Q4 2020 Feb 12, 2021	SELL	$5.98 - $12.47 $5,083 - $10,599	-850 Reduced 50.18%	844 $7,000
Q3 2020 Nov 06, 2020	BUY	$4.65 - $8.73 $7,770 - $14,587	1,671 Added 7265.22%	1,694 $10,000
Q2 2020 Aug 07, 2020	BUY	$4.66 - $8.7 $107 - $200	23 New	23 $0
Q1 2020 May 08, 2020	SELL	$5.05 - $15.01 $85 - $255	-17 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$6.32 - $19.66 $107 - $334	17 New	17 $0

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.